Loading asset research
Enveric Biosciences Inc. Common Stock
ENVBNasdaq · USD · StocksQuote as of · Exchange session not verified$1.54
-1.28%
Today
ENVB
Loading 1D prices…
Market cap
$6.7M
Volume
84.7K
52w high
$13.2552w low
$1.17Company profile
Enveric Biosciences Inc. Common Stock
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
CAMBRIDGE, MA, United States
Employees
5
Fiscal year end
1231
CIK
890821
Session & valuation
Open$1.57
Previous close$1.57
Day high$1.58
Day low$1.48
30-day avg. volume99.8K
Outstanding shares4.5M
Diluted EPS-$36.24
Latest annual period
P/E (trailing)-0.04
P/E (forward)-1.06
Price / book0.73
Beta1.11
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| BOLTBolt Biotherapeutics Inc. Common Stock | $6.9M | $7.7M | -433.74% | -$17.85 | -1.64% | Hold |
| LEXXLexaria Bioscience Corp. Common Stock | $7.2M | $20K | -25180.94% | -$0.21 | +3.86% | Buy |
| PULMPulmatrix Inc. Common Stock | $6M | $0.00 | — | -$1.41 | -0.89% | Unrated |
| SKYESkye Bioscience Inc. Common Stock | $7.5M | $0.00 | — | -$1.41 | -5.56% | Buy |
| CURXCuranex Pharmaceuticals Inc Common Stock | $7.6M | $0.00 | — | -$0.17 | +3.80% | Unrated |